RxDoctor Payments Data

Namrata Daru, DPM

Foot & Ankle Surgery · Suffolk, VANPI 1528529963

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (43.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Arthrex at 30.8% of the total. Reporting peaked in 2022 at $7,510 and has fallen 68.3% since, to $2,382 in 2025.

$11,062in general payments, 2019–2025

Across 70 payments — averaging $158.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$3K
  • Fortis Surgical, LLC$3K
  • Stryker$3K
  • Integra Lifesciences Corporation$982
  • Kerecis Limited$520
  • Anika Therapeutics, Inc.$273
  • plus $348 from 5 others

What the payments were for

  • Travel & lodging$1,44813%
  • Food & beverage$3,83235%
  • Education$4,80043%
  • Other$9829%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,062 in reported general payments places this provider in the 80th percentile of 260 foot & ankle surgery providers in Virginia.

See all foot & ankle surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$74,571
Medicare patients
275
Services billed
1,030

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox89$2,185
Diclofenac Sodium96$1,927
Ammonium Lactate99$1,377
Ketoconazole64$950
Terbinafine Hcl13$336
Methylprednisolone47$290
Doxycycline Hyclate26$180
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen16$151
Ciprofloxacin Hcl18$138
Meloxicam34$79
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim11$58

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Suffolk

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →